[An automatic implantable heart rhythm converter and defibrillator]

Area of Science:

• Cardiology
• Biomedical Engineering
• Medical Devices

Background:

• Ventricular tachycardia and fibrillation are life-threatening cardiac dysrhythmias.
• DC-countershock is an established method for restoring normal sinus rhythm.
• The need for rapid, accessible treatment for these arrhythmias is critical.

Observation:

• An implantable cardioverter defibrillator (ICD) continuously monitors heart rhythm.
• The ICD automatically detects episodes of ventricular tachycardia and ventricular fibrillation.
• Upon detection, the ICD delivers one or more DC-counter shocks within seconds.

Findings:

• The developed implantable cardioverter defibrillator (ICD) provides automated and rapid treatment for ventricular tachycardia and fibrillation.
• The device ensures timely intervention, improving patient outcomes by delivering shocks even when outside a hospital.
• Case histories demonstrate the efficacy and practical application of ICD therapy.

Implications:

• Implantable cardioverter defibrillators offer a significant advancement in the management of life-threatening cardiac arrhythmias.
• Continuous monitoring and automated defibrillation by ICDs enhance patient safety and reduce mortality.
• This technology facilitates prompt treatment, extending critical care beyond hospital settings.